Impact of New Chemotherapeutic and Targeted Agents on Survival in Stage IV Non-Small Cell Lung Cancer

PURPOSE. Significant advances in the systemic management of metastatic non-small cell lung cancer (NSCLC) have occurred over the past decade, with options now including multiple lines of chemotherapy, epidermal growth factor receptor inhibitors, and antiangiogenic agents. Improvements in overall sur...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yu, Joanne L., Simmons, Christine, Victor, J. Charles, Han, Dolly, Hogeveen, Sophie, Leighl, Natasha, Verma, Sunil
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2011
Témata:
Lung Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228167/
https://ncbi.nlm.nih.gov/pubmed/21835896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0079
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky